4 4 diaminodiphenylsulfone

Deferoxamine, ferrostatin-1, erastin, sulfacetamide, sulfasalazine (SSZ), zymosan, diphenyleneiodonium chloride (DPI), 4,4′-diaminodiphenyl sulfone (DDS), sulfisoxazole, tBHP, and sulfasalazine were purchased from Sigma. Phorbol 12-myristate 13-acetate (PMA), sulfamethoxazole, sulfanilamide, sulfapyridine, 5-aminosalicylic acid (5-ASA), sulfadimidine, sulfametoxydiazine, sulfisomidine, sulfanitran, sulfanilamide, and piroxicam were purchased from Wako. We purchased 1-O-hexadecyl-2-arachidonoyl-sn-glycero-3-phosphocholine (ether-linked phosphatidylcholine) from Avanti polar lipids. Necrostatin-1 was purchased from FOCUS Biomolecules, and 2-mercaptoethanol was purchased from MP Biomedicals. z-VAD-fmk was purchased from Peptide institute. Trolox, sulfadiazine, sulfadimethoxine, sulfadoxin, and sulfamethoxypyridazine were purchased from Tokyo Chemical Industry. Cl-amidine was purchased from Cayman chemicals. Ionomycin was purchased from Merck Millipore.

1H-imidazole, 3-chloroperoxybenzoic acid (77%), 3-(aminomethyl)-3,5,5-trimethylcyclohexanamine (IPD), 4,4’-diaminodiphenylsulfone (DDS), and trimethyl-1,6-hexanediamine (TMHMDA) were obtained from Sigma-Aldrich (St. Louis, MO, USA). 4-bromo-1-butene and lithium bis(trifluoromethane)sulfonimide were purchased from ABCR (Karlsruhe, Germany). 4-methyl-hexahydro-phthalic anhydride (MHHPA) and bisphenol A diglycidyl ether (DGEBA) were supplied by Huntsman (The Woodlands, TX, USA). N,N-dimethylbenzylamine (BDMA) was purchased from Fisher Scientific (Hampton, NH, USA). All chemicals were used without further purification.